Literature DB >> 8254779

Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein.

T L Lewis1, H B Greenberg, J E Herrmann, L S Smith, S M Matsui.   

Abstract

We report the results from sequence analysis and expression studies of the gastroenteritis agent astrovirus serotype 1. We have cloned and sequenced 5,944 nucleotides (nt) of the estimated 7.2-kb RNA genome and have identified three open reading frames (ORFs). ORF-3, at the 3' end, is 2,361 nt in length and is fully encoded in both the genomic and subgenomic viral RNAs. Expression of ORF-3 in vitro yields an 87-kDa protein that is immunoprecipitated with a monoclonal antibody specific for viral capsids. This protein comigrates with an authentic 87-kDa astrovirus protein immunoprecipitated from infected cells, indicating that this region encodes a viral structural protein. The adjacent upstream ORF (ORF-2) is 1,557 nt in length and contains a viral RNA-dependent RNA polymerase motif. The viral RNA-dependent RNA polymerase motifs from four astrovirus serotypes are compared. Partial sequence (2,018 nt) of the most 5' ORF (ORF-1) reveals a 3C-like serine protease motif. The ORF-1 sequence is incomplete. These results indicate that the astrovirus genome is organized with nonstructural proteins encoded at the 5' end and structural proteins at the 3' end. ORF-2 has no start methionine and is in the -1 frame compared with ORF-1. We present sequence evidence for a ribosomal frameshift mechanism for expression of the viral polymerase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254779      PMCID: PMC236266     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  The 3' terminal sequence of a human astrovirus.

Authors:  M M Willcocks; M J Carter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.

Authors:  W Wilson; M Braddock; S E Adams; P D Rathjen; S M Kingsman; A J Kingsman
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

4.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

5.  Antigenic characterization of cell-cultivated astrovirus serotypes and development of astrovirus-specific monoclonal antibodies.

Authors:  J E Herrmann; R W Hudson; D M Perron-Henry; J B Kurtz; N R Blacklow
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

Review 6.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

7.  Sobemovirus genome appears to encode a serine protease related to cysteine proteases of picornaviruses.

Authors:  A E Gorbalenya; E V Koonin; V M Blinov; A P Donchenko
Journal:  FEBS Lett       Date:  1988-08-29       Impact factor: 4.124

8.  An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA.

Authors:  M Chamorro; N Parkin; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

10.  In vitro translation of a subgenomic mRNA from purified virions of the Spanish field isolate AST/89 of rabbit hemorrhagic disease virus (RHDV).

Authors:  J A Boga; M S Marín; R Casais; M Prieto; F Parra
Journal:  Virus Res       Date:  1992-10       Impact factor: 3.303

View more
  43 in total

1.  Proteolytic processing of the astrovirus capsid.

Authors:  D M Bass; S Qiu
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Processing of nonstructural protein 1a of human astrovirus.

Authors:  Ute Geigenmüller; Teri Chew; Nancy Ginzton; Suzanne M Matsui
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Detection and sequence analysis of Danish and Swedish strains of mink astrovirus.

Authors:  Christian Mittelholzer; Lena Englund; Kjell-Olof Hedlund; Hans-Henrik Dietz; Lennart Svensson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

4.  C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic reticulum and viral RNA.

Authors:  Susana Guix; Santiago Caballero; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 5.  Identification of structural domains involved in astrovirus capsid biology.

Authors:  Neel K Krishna
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

6.  Detection of infectious astroviruses in water.

Authors:  R M Pinto; F X Abad; R Gajardo; A Bosch
Journal:  Appl Environ Microbiol       Date:  1996-05       Impact factor: 4.792

7.  Crystal structure of the avian astrovirus capsid spike.

Authors:  Rebecca M DuBois; Pamela Freiden; Shauna Marvin; Muralidhar Reddivari; Richard J Heath; Stephen W White; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

8.  Astrovirus ribosomal frameshifting in an infection-transfection transient expression system.

Authors:  T L Lewis; S M Matsui
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein.

Authors:  P Liston; D J Briedis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Authors:  Rheba S Bonaparte; Pamela S Hair; Deepa Banthia; Dawn M Marshall; Kenji M Cunnion; Neel K Krishna
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.